Artykuły w czasopismach na temat „Generation of negative triples”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Generation of negative triples”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Vallée-Tourangeau, Frédéric, Neville G. Austin i Sandra Rankin. "Inducing a Rule in Wason's 2–4–6 Task: A Test of the Information-Quantity and Goal-Complementarity Hypotheses". Quarterly Journal of Experimental Psychology Section A 48, nr 4 (listopad 1995): 895–914. http://dx.doi.org/10.1080/14640749508401422.
Pełny tekst źródłaVallée-Tourangeau, Frédéric. "Utilities in the 2-4-6 Task". Experimental Psychology 59, nr 5 (1.05.2012): 265–71. http://dx.doi.org/10.1027/1618-3169/a000152.
Pełny tekst źródłaWang, Liuquan. "Arithmetic identities and congruences for partition triples with 3-cores". International Journal of Number Theory 12, nr 04 (10.04.2016): 995–1010. http://dx.doi.org/10.1142/s1793042116500627.
Pełny tekst źródłaTierno, Domenico, Gabriele Grassi, Serena Scomersi, Marina Bortul, Daniele Generali, Fabrizio Zanconati i Bruna Scaggiante. "Next-Generation Sequencing and Triple-Negative Breast Cancer: Insights and Applications". International Journal of Molecular Sciences 24, nr 11 (2.06.2023): 9688. http://dx.doi.org/10.3390/ijms24119688.
Pełny tekst źródłaWu, Jiande, Tarun K. K. Mamidi, Lu Zhang i Chindo Hicks. "Delineation of the Germline and Somatic Mutation Interaction Landscape in Triple-Negative and Non-Triple-Negative Breast Cancer". International Journal of Genomics 2020 (7.07.2020): 1–16. http://dx.doi.org/10.1155/2020/2641370.
Pełny tekst źródłaLin, Po‐Han, Ming Chen, Li‐Wei Tsai, Chiao Lo, Tzu‐Chun Yen, Thomas Yoyan Huang, Chih‐Kai Chen, Sheng‐Chih Fan, Sung‐Hsin Kuo i Chiun‐Sheng Huang. "Using next‐generation sequencing to redefine BRCAness in triple‐negative breast cancer". Cancer Science 111, nr 4 (19.02.2020): 1375–84. http://dx.doi.org/10.1111/cas.14313.
Pełny tekst źródłaWu, Jiande, Tarun Karthik Kumar Mamidi, Lu Zhang i Chindo Hicks. "Unraveling the Genomic-Epigenomic Interaction Landscape in Triple Negative and Non-Triple Negative Breast Cancer". Cancers 12, nr 6 (12.06.2020): 1559. http://dx.doi.org/10.3390/cancers12061559.
Pełny tekst źródłaRaftery, Martin J., Alexander Sebastian Franzén, Clarissa Radecke, Abdelhadi Boulifa, Günther Schönrich, Sebastian Stintzing, Jens-Uwe Blohmer i Gabriele Pecher. "Next Generation CD44v6-Specific CAR-NK Cells Effective against Triple Negative Breast Cancer". International Journal of Molecular Sciences 24, nr 10 (20.05.2023): 9038. http://dx.doi.org/10.3390/ijms24109038.
Pełny tekst źródłaZhang, Zhenghang, Jinlu Jia, Yalin Wan, Yang Zhou, Yuting Kong, Yurong Qian i Jun Long. "TransR*: Representation learning model by flexible translation and relation matrix projection". Journal of Intelligent & Fuzzy Systems 40, nr 5 (22.04.2021): 10251–59. http://dx.doi.org/10.3233/jifs-202177.
Pełny tekst źródłaBen-Baruch, Noa, Tamar Peretz-Yablonski, Georgeta Fried, Moshe J. Inbar, Yousef Samih, Victoria Neiman, Bella Nisenbaum i in. "Next-generation sequencing (NGS) in relapsed/refractory triple-negative breast cancer (TNBC) in Israel." Journal of Clinical Oncology 32, nr 15_suppl (20.05.2014): 1028. http://dx.doi.org/10.1200/jco.2014.32.15_suppl.1028.
Pełny tekst źródłaThouvenot, B., S. Verdun, J. Tomasina, B. Hilselberger, M. Brulliard, L. Bonnard, M. Trarbach, J. Armand, V. Ogier i B. E. Bihain. "P272 Using next-generation sequencing to predict clinical outcome of triple negative breast cancer". Breast 24 (marzec 2015): S120. http://dx.doi.org/10.1016/s0960-9776(15)70304-8.
Pełny tekst źródłaElsayed, Islam, i Yoshiki Nishi. "A Feasibility Study on Power Generation from Solar Thermal Wind Tower: Inclusive Impact Assessment Concerning Environmental and Economic Costs". Energies 11, nr 11 (16.11.2018): 3181. http://dx.doi.org/10.3390/en11113181.
Pełny tekst źródłaCaiazza, Francesco, Alyson Murray, Stephen F. Madden, Naoise C. Synnott, Elizabeth J. Ryan, Norma O’Donovan, John Crown i Michael J. Duffy. "Preclinical evaluation of the AR inhibitor enzalutamide in triple-negative breast cancer cells". Endocrine-Related Cancer 23, nr 4 (kwiecień 2016): 323–34. http://dx.doi.org/10.1530/erc-16-0068.
Pełny tekst źródłaLips, Esther H., Magali Michaut, Lennart Mulder, Nicolle Besselink, Marlous L. Hoogstraat, Marco J. Koudijs, Emile E. Voest i in. "Next-generation sequencing to find predictors for chemotherapy response in triple-negative breast cancer (TNBC)." Journal of Clinical Oncology 31, nr 15_suppl (20.05.2013): 1010. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.1010.
Pełny tekst źródłaHu, Zhiwei, Rulong Shen, Amanda Campbell, Elizabeth McMichael, Lianbo Yu, Bhuvaneswari Ramaswamy, Cheryl A. London, Tian Xu i William E. Carson. "Targeting Tissue Factor for Immunotherapy of Triple-Negative Breast Cancer Using a Second-Generation ICON". Cancer Immunology Research 6, nr 6 (5.04.2018): 671–84. http://dx.doi.org/10.1158/2326-6066.cir-17-0343.
Pełny tekst źródłaWang, Wei, Hao Chen, Yang Xie, Sayantap Datta, Wei Li i Ruiwen Zhang. "Abstract 678: Experimental therapy of triple negative breast cancer with next-generation of MDM2 inhibitors". Cancer Research 84, nr 6_Supplement (22.03.2024): 678. http://dx.doi.org/10.1158/1538-7445.am2024-678.
Pełny tekst źródłaDenu, Ryan A., Cissimol P. Joseph, Elizabeth S. Urquiola, Precious S. Byrd, Richard K. Yang, Ravin Ratan, Maria Alejandra Zarzour i in. "Utility of Clinical Next Generation Sequencing Tests in KIT/PDGFRA/SDH Wild-Type Gastrointestinal Stromal Tumors". Cancers 16, nr 9 (27.04.2024): 1707. http://dx.doi.org/10.3390/cancers16091707.
Pełny tekst źródłaKareev, Yaakov, Naftali Halberstadt i Dorit Shafir. "Improving Performance and Increasing the Use of Non-Positive Testing in a Rule-Discovery Task". Quarterly Journal of Experimental Psychology Section A 46, nr 4 (listopad 1993): 729–42. http://dx.doi.org/10.1080/14640749308401036.
Pełny tekst źródłaHossain, Fokhrul, Samarpan Majumder, Justin David i Lucio Miele. "Precision Medicine and Triple-Negative Breast Cancer: Current Landscape and Future Directions". Cancers 13, nr 15 (26.07.2021): 3739. http://dx.doi.org/10.3390/cancers13153739.
Pełny tekst źródłaAlewine, Christine, Laiman Xiang, Takao Yamori, Gerhard Niederfellner, Klaus Bosslet i Ira Pastan. "Efficacy of RG7787, a Next-Generation Mesothelin-Targeted Immunotoxin, against Triple-Negative Breast and Gastric Cancers". Molecular Cancer Therapeutics 13, nr 11 (19.09.2014): 2653–61. http://dx.doi.org/10.1158/1535-7163.mct-14-0132.
Pełny tekst źródłaZhu, X., J. Bayani, M. Dewan, H. Tovey, L. Kilburn, K. Taylor, J. Banerji i in. "307P Identifying new biological subgroups of triple-negative breast cancer using next-generation integrative clustering pipeline". Annals of Oncology 34 (październik 2023): S306—S307. http://dx.doi.org/10.1016/j.annonc.2023.09.503.
Pełny tekst źródłaBhattarai, Shristi, Geetanjali Saini, Hongxiao Li, Gaurav Seth, Timothy B. Fisher, Emiel A. M. Janssen, Umay Kiraz, Jun Kong i Ritu Aneja. "Predicting Neoadjuvant Treatment Response in Triple-Negative Breast Cancer Using Machine Learning". Diagnostics 14, nr 1 (28.12.2023): 74. http://dx.doi.org/10.3390/diagnostics14010074.
Pełny tekst źródłaKhandelwal, Soni, Mallory Boylan, Gilbert Kirsch, Julian E. Spallholz i Lauren S. Gollahon. "Investigating the Potential of Conjugated Selenium Redox Folic Acid as a Treatment for Triple Negative Breast Cancer". Antioxidants 9, nr 2 (5.02.2020): 138. http://dx.doi.org/10.3390/antiox9020138.
Pełny tekst źródłaPircher, Magdalena, Thomas Winder i Andreas Trojan. "Response to Vemurafenib in Metastatic Triple-Negative Breast Cancer Harbouring a BRAF V600E Mutation: A Case Report and Electronically Captured Patient-Reported Outcome". Case Reports in Oncology 14, nr 1 (29.03.2021): 616–21. http://dx.doi.org/10.1159/000513905.
Pełny tekst źródłaHerrera Juarez, Mercedes, Pablo Tolosa Ortega, Ana Sanchez de Torre i Eva Ciruelos Gil. "Biology of the Triple-Negative Breast Cancer: Immunohistochemical, RNA, and DNA Features". Breast Care 15, nr 3 (2020): 208–16. http://dx.doi.org/10.1159/000508758.
Pełny tekst źródłaDesa, Danielle E., Wencheng Wu, Robert M. Brown, Edward B. Brown, Robert L. Hill, Bradley M. Turner i Edward B. Brown. "Second-Harmonic Generation Imaging Reveals Changes in Breast Tumor Collagen Induced by Neoadjuvant Chemotherapy". Cancers 14, nr 4 (9.02.2022): 857. http://dx.doi.org/10.3390/cancers14040857.
Pełny tekst źródłaYang, Biyao, Rui Sang, Yi Li, Ewa Goldys i Wei Deng. "Abstract 5743: Liposome platform enables X-ray induced photodynamic therapy treatment against human triple negative breast cancer cells". Cancer Research 84, nr 6_Supplement (22.03.2024): 5743. http://dx.doi.org/10.1158/1538-7445.am2024-5743.
Pełny tekst źródłaNagahashi, Masayuki, Tetsu Hayashida, Yuko Kitagawa, Manabu Futamura, Kazuhiro Yoshida, Takashi Kuwayama, Seigo Nakamura i in. "Comprehensive genomic sequencing for triple negative breast cancer in Japan." Journal of Clinical Oncology 35, nr 15_suppl (20.05.2017): e23122-e23122. http://dx.doi.org/10.1200/jco.2017.35.15_suppl.e23122.
Pełny tekst źródłaAshourpour, Maryam, Fatemeh Mostafavi Hosseini, Mohsen Amini, Ebrahim Saeedian Moghadam, Faranak Kazerouni, Seyed Yousef Arman i Zahra Shahsavari. "Pyrazole Derivatives Induce Apoptosis via ROS Generation in the Triple Negative Breast Cancer Cells, MDA-MB-468". Asian Pacific Journal of Cancer Prevention 22, nr 7 (1.07.2021): 2079–87. http://dx.doi.org/10.31557/apjcp.2021.22.7.2079.
Pełny tekst źródłaWeisman, Paul S., Charlotte K. Y. Ng, Edi Brogi, Rachel E. Eisenberg, Helen H. Won, Salvatore Piscuoglio, Maria R. De Filippo i in. "Genetic alterations of triple negative breast cancer by targeted next-generation sequencing and correlation with tumor morphology". Modern Pathology 29, nr 5 (4.03.2016): 476–88. http://dx.doi.org/10.1038/modpathol.2016.39.
Pełny tekst źródłaSangiorgio, Valentina, Rocco Giovanni Piazza, Federica Mottadelli, Fabio Pagni, Inzoli Elena, Carlo Gambacorti-Passerini, Gianni Cazzaniga i Elena Maria Elli. "P1056: NEXT GENERATION SEQUENCING IDENTIFIES SUBGROUPS OF PATIENTS WITH TRIPLE NEGATIVE/ PRIMARY THROMBOCYTOSIS WITH DIFFERENT CLINICAL OUTCOMES". HemaSphere 7 (sierpień 2023): e7820571. http://dx.doi.org/10.1097/01.hs9.0000971120.78205.71.
Pełny tekst źródłaBerisha, Eranda, Maria del Carmen Chacon Castro, Adnin Ashrafi, Narges Salamat, Parinaz Sadat Alemi i Li Zhang. "Abstract 4942: Heme targeting and its mechanistic role in triple-negative breast cancer suppression". Cancer Research 83, nr 7_Supplement (4.04.2023): 4942. http://dx.doi.org/10.1158/1538-7445.am2023-4942.
Pełny tekst źródłaYun, Jiwon, Jung-Ah Kim, Byungjin Hwang, Hee Sue Park, Kyongok Im, Sung-Min Kim, Dajeong Jeong, Kyu Min Lim, Duhee Bang i Dong Soon Lee. "Triple-Negative Myeloproliferative Neoplasms Vs. Calr, JAK2 or MPL-Mutated Myeloproliferative Neoplasms: Distinct Molecular Characteristics". Blood 132, Supplement 1 (29.11.2018): 1772. http://dx.doi.org/10.1182/blood-2018-99-118013.
Pełny tekst źródłaMorris, Lindsay Kaye, Matthew Stein, Saradasri Karri, Srishti Sareen, Kruti Patel, Gregory A. Vidal, Lee Steven Schwartzberg i Michael Gary Martin. "Distribution of receptor tyrosine kinase (RTK) nsSNPs in breast cancer (BC) patients (pts) using next-generation sequencing (NGS)." Journal of Clinical Oncology 35, nr 15_suppl (20.05.2017): 1080. http://dx.doi.org/10.1200/jco.2017.35.15_suppl.1080.
Pełny tekst źródłaKalyane, Dnyaneshwar, Suryanarayana Polaka, Nupur Vasdev i Rakesh Kumar Tekade. "CD44-Receptor Targeted Gold-Doxorubicin Nanocomposite for Pulsatile Chemo-Photothermal Therapy of Triple-Negative Breast Cancer Cells". Pharmaceutics 14, nr 12 (6.12.2022): 2734. http://dx.doi.org/10.3390/pharmaceutics14122734.
Pełny tekst źródłaSvidnicki, Maria Carolina Costa Melo, Paula De Melo Campos, Moisés Alves Ferreira Filho, Caio Augusto Leme Fujiura, Tetsuichi Yoshizato, Hideki Makishima, Seishi Ogawa i Sara T. Olalla Saad. "Mutations in Triple-Negative Patients with Myeloproliferative Neoplasms". Blood 134, Supplement_1 (13.11.2019): 5395. http://dx.doi.org/10.1182/blood-2019-128764.
Pełny tekst źródłaDameri, Martina, Lorenzo Ferrando, Gabriella Cirmena, Claudio Vernieri, Giancarlo Pruneri, Alberto Ballestrero i Gabriele Zoppoli. "Multi-Gene Testing Overview with a Clinical Perspective in Metastatic Triple-Negative Breast Cancer". International Journal of Molecular Sciences 22, nr 13 (1.07.2021): 7154. http://dx.doi.org/10.3390/ijms22137154.
Pełny tekst źródłaBahman, Fatemah, Valeria Pittalà, Mohamed Haider i Khaled Greish. "Enhanced Anticancer Activity of Nanoformulation of Dasatinib against Triple-Negative Breast Cancer". Journal of Personalized Medicine 11, nr 6 (15.06.2021): 559. http://dx.doi.org/10.3390/jpm11060559.
Pełny tekst źródłaHe, W., Y. Zhang, Y. Deng i D. Kabelitz. "Induction of TCR-gamma delta expression on triple-negative (CD3-4-8-) human thymocytes. Comparative analysis of the effects of IL-4 and IL-7." Journal of Immunology 154, nr 8 (15.04.1995): 3726–31. http://dx.doi.org/10.4049/jimmunol.154.8.3726.
Pełny tekst źródłaBian, Yanlin, Tong Lin, Tanja Jakos, Xiaodong Xiao i Jianwei Zhu. "The Generation of Dual-Targeting Fusion Protein PD-L1/CD47 for the Inhibition of Triple-Negative Breast Cancer". Biomedicines 10, nr 8 (30.07.2022): 1843. http://dx.doi.org/10.3390/biomedicines10081843.
Pełny tekst źródłaWang, Nan, Kun Li, Wenfa Huang, Weiyao Kong, Xiaoran Liu, Weijie Shi, Feng Xie i in. "Efficacy of platinum in advanced triple-negative breast cancer with germline BRCA mutation determined by next generation sequencing". Chinese Journal of Cancer Research 32, nr 2 (2020): 149–62. http://dx.doi.org/10.21147/j.issn.1000-9604.2020.02.03.
Pełny tekst źródłaHuang, Xin, Huanwen M. Wu, Changbin Zhu, Di Shao, Dan Guo, Yidong Zhou, Yan Lin i in. "Next generation sequencing reveals CCNE1 amplification as an independent prognostic factor for triple negative breast cancer (TNBC) patients." Journal of Clinical Oncology 38, nr 15_suppl (20.05.2020): 558. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.558.
Pełny tekst źródłaLanders, Mark, Rhonda Meredith, Jerry Lee, Yipeng Wang, Byung-In Lee i Joseph Monforte. "Next-generation sequencing mutational analysis of triple-negative breast cancer patients from matched FFPE and fresh frozen samples." Journal of Clinical Oncology 30, nr 15_suppl (20.05.2012): 1058. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.1058.
Pełny tekst źródłaAnders, Carey K., Vandana Abramson, Tira Tan i Rebecca Dent. "The Evolution of Triple-Negative Breast Cancer: From Biology to Novel Therapeutics". American Society of Clinical Oncology Educational Book, nr 36 (maj 2016): 34–42. http://dx.doi.org/10.1200/edbk_159135.
Pełny tekst źródłaKhadela, Avinash, Vivek P. Chavda, Shruti Soni, Kaivalya Megha, Aanshi J. Pandya i Lalitkumar Vora. "Anti-Androgenic Therapies Targeting the Luminal Androgen Receptor of a Typical Triple-Negative Breast Cancer". Cancers 15, nr 1 (30.12.2022): 233. http://dx.doi.org/10.3390/cancers15010233.
Pełny tekst źródłaAndreidesz, Kitti, Balazs Koszegi, Dominika Kovacs, Viola Bagone Vantus, Ferenc Gallyas i Krisztina Kovacs. "Effect of Oxaliplatin, Olaparib and LY294002 in Combination on Triple-Negative Breast Cancer Cells". International Journal of Molecular Sciences 22, nr 4 (19.02.2021): 2056. http://dx.doi.org/10.3390/ijms22042056.
Pełny tekst źródłaShiau, Jun-Ping, Cheng-Che Wu, Shu-Jyuan Chang, Mei-Ren Pan, Wangta Liu, Fu Ou-Yang, Fang-Ming Chen, Ming-Feng Hou, Shen-Liang Shih i Chi-Wen Luo. "FAK Regulates VEGFR2 Expression and Promotes Angiogenesis in Triple-Negative Breast Cancer". Biomedicines 9, nr 12 (29.11.2021): 1789. http://dx.doi.org/10.3390/biomedicines9121789.
Pełny tekst źródłaSubhan, Md Abdus, Farzana Parveen, Hassan Shah, Satya Siva Kishan Yalamarty, Janaína Artem Ataide i Valdimir P. Torchilin. "Recent Advances with Precision Medicine Treatment for Breast Cancer including Triple-Negative Sub-Type". Cancers 15, nr 8 (8.04.2023): 2204. http://dx.doi.org/10.3390/cancers15082204.
Pełny tekst źródłaJagadish, Nirmala, Sonika Devi, Namita Gupta, Vitusha Suri i Anil Suri. "Knockdown of A-kinase anchor protein 4 inhibits proliferation of triple-negative breast cancer cells in vitro and in vivo". Tumor Biology 42, nr 4 (kwiecień 2020): 101042832091447. http://dx.doi.org/10.1177/1010428320914477.
Pełny tekst źródłaMohammadhosseinpour, Sepideh, Alexx Weaver, Meenakshi Sudhakaran, Linh-Chi Ho, Tra Le, Andrea I. Doseff i Fabricio Medina-Bolivar. "Arachidin-1, a Prenylated Stilbenoid from Peanut, Enhances the Anticancer Effects of Paclitaxel in Triple-Negative Breast Cancer Cells". Cancers 15, nr 2 (7.01.2023): 399. http://dx.doi.org/10.3390/cancers15020399.
Pełny tekst źródła